| Evaluation of the Effect of Artesunate in Friedreich Ataxia (FA) (NCT04921930) | Institut National de la Santé Et de la Recherche Médicale, France | 2022-05-06 |
| Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia (NCT05285540) | Design Therapeutics, Inc. | 2022-03-11 |
| FRDA Investigator Initiated Study (IIS) With Elamipretide (NCT05168774) | Children's Hospital of Philadelphia | 2022-03-03 |
| Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia (NCT05302271) | Weill Medical College of Cornell University | 2022-02-22 |
| Evaluation of the Effects of Calcitriol's in the Neurological Symptoms of Friedreich's Ataxia Patients (NCT04801303) | Berta Alemany | 2021-08-25 |
| Determine Range of Tissue Frataxin Concentrations and Other Potential Biomarkers (NCT05028764) | Larimar Therapeutics, Inc. | 2021-08-04 |
| NAD+ Precursor Supplementation in Friedreich's Ataxia (NCT04817111) | Metro International Biotech, LLC | 2021-05-17 |
| Coronary Artery Disease in Patients With Friedreich's Ataxia (NCT04649866) | University of Pittsburgh | 2021-02-15 |
| A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals with Friedreich Ataxia (TRACK-FA) (NCT04349514) | Monash University | 2021-02-10 |
| Home Based Tele-exercise for People With Chronic Neurological Impairments (NCT04564495) | Burke Medical Research Institute | 2021-01-22 |
| A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia (NCT04577352) | PTC Therapeutics | 2020-12-17 |
| Safety and Efficacy of Etravirine in Friedreich Ataxia Patients (NCT04273165) | IRCCS Eugenio Medea | 2020-09-17 |
| Multiple Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia (NCT04519567) | Larimar Therapeutics, Inc. | 2020-07-31 |
| Characterization of the Interruptions of the GAA Expansion and Study of Their Influence on the Severity of Friedreich's Ataxia (NCT04346238) | University Hospital, Montpellier | 2020-03-01 |
| A Study to Assess Variation in Potential Biomarkers in Friedreich Ataxia (NCT04255680) | Larimar Therapeutics, Inc. | 2020-01-14 |
| Single Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia (NCT04176991) | Larimar Therapeutics, Inc. | 2019-12-11 |
| Instrumented Data Exchange for Ataxia Study (NCT04268147) | University of Chicago | 2019-06-01 |
| Micronised Resveratrol as a Treatment for Friedreich Ataxia (NCT03933163) | Murdoch Childrens Research Institute | 2019-05-23 |
| A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients (NCT03917225) | Minoryx Therapeutics, S.L. | 2019-03-26 |
| Neurology Measures in FA Children (NCT03418740) | Children's Hospital of Philadelphia | 2017-11-20 |
| Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia (NCT03214588) | Neurocrine Biosciences | 2017-11-08 |
| TCA Cycle in the Dentate in Friedreich's Ataxia (NCT03122925) | University of Minnesota | 2017-08-29 |
| Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia (NCT03120013) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2017-02-06 |
| Open Trail of γIFN for Friedreich Ataxia (NCT03888664) | IRCCS Eugenio Medea | 2016-06-26 |
| Rosuvastatin (Crestor) in Friedreich Ataxia (NCT02705547) | Children's Hospital of Philadelphia | 2016-05-01 |
| Genetic and Environmental Determinants That Control Metabolism in Pulmonary Hypertension (NCT02594917) | University of Pittsburgh | 2015-10-01 |
| Methylprednisolone Treatment of Friedreich Ataxia (NCT02424435) | Children's Hospital of Philadelphia | 2015-06-01 |
| Longitudinal Analysis of Oral Communication in Friedreich's Ataxia (NCT04631224) | Institut National de la Santé Et de la Recherche Médicale, France | 2015-02-01 |
| A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's Ataxia (NCT02255435) | Biogen | 2015-01-31 |
| Interferon Gamma-1b in Friedreich Ataxia (FRDA) (NCT01965327) | Children's Hospital of Philadelphia | 2013-08-01 |
| A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients (NCT02035020) | Azienda Policlinico Umberto I | 2013-05-01 |
| Efficacy Study of Epoetin Alfa in Friedreich Ataxia (NCT01493973) | Federico II University | 2013-01-01 |
| An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia (NCT01716221) | University of Colorado, Denver | 2012-10-01 |
| A Study of Resveratrol as Treatment for Friedreich Ataxia (NCT01339884) | Murdoch Childrens Research Institute | 2011-04-01 |
| Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (NCT01793168) | Sanford Health | 2010-07-01 |
| Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia (NCT00824512) | Ipsen | 2008-06-01 |
| Idebenone to Treat Friedreich's Ataxia (NCT00229632) | National Institute of Neurological Disorders and Stroke (NINDS) | 2005-09-27 |
| Iron-Chelating Therapy and Friedreich Ataxia (NCT00224640) | Assistance Publique - Hôpitaux de Paris | 2005-03-01 |
| Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia (NCT00078481) | National Institute of Neurological Disorders and Stroke (NINDS) | 2004-02-01 |
| Transitional Life Events in Patients With Friedreich's Ataxia: Implications for Genetic Counseling (NCT00056186) | National Human Genome Research Institute (NHGRI) | 2003-03-01 |
| Safety Study of Idebenone to Treat Friedreich's Ataxia (NCT00015808) | National Institute of Neurological Disorders and Stroke (NINDS) | 2001-05-01 |
| FA Clinical Outcome Measures (NCT03090789) | Friedreich's Ataxia Research Alliance | 2001-01-01 |